Stanford Bio-X

Brain organoids are reshaping neuroscience. To scale up their work, Wu Tsai Neuro affiliates @Sergiu_P_Pasca, @HeilshornSarah & team found an unexpected solution: xanthan gum. This simple solution could speed up discovery in brain development and disease. neuroscience.stanford.edu/news/common-fo…

An antibody treatment developed at Stanford Medicine can prepare patients for stem cell transplantation, sparing them toxic side effects, a Phase 1 clinical trial found. med.stanford.edu/news/all-news/…

Can your immune system predict *how* sick you'll get? @StanfordMed led research finds signs of immune dysfunction before infection can forecast severity. Featuring #StanDOM's @purveshkhatri 👉 stan.md/4k8qIT9

Stanford Medicine researchers have developed a lipid‑nanoparticle mRNA approach to engineer and track CAR‑T cells inside the body to eliminate cancer. med.stanford.edu/news/all-news/…

“AI is ripe for legal innovation—but high stakes demand caution,” says @StanfordLaw prof Dan Ho. In this @StanfordEng podcast, Ho explains how AI helped counties erase racist housing covenants in days & why sloppy use still leads to 80%+ hallucinations. 🎧 engineering.stanford.edu/news/future-ai…

A Stanford Medicine-led study has found that better stenting practices now mean that implanting stents is about as effective in preventing death and stroke as bypass surgery — though outcomes depend on individual cases. stan.md/3EOJ50J

Groundbreaking innovations that begin in Stanford labs flow freely into private industry to improve human well-being, fuel the economy, and strengthen American competitiveness. 🔬

A blood-test analysis developed at Stanford Medicine can determine the “biological ages” of 11 separate organ systems in individuals’ bodies and predict the health consequences. med.stanford.edu/news/all-news/…

In CS 123, students bring together artificial intelligence and engineering fundamentals to design and upgrade “Pupper,” a walking quadruped robot. 🤖 🗞️: stanford.io/4kNqjGh

Stanford Medicine researchers have found that rare neuroendocrine cells in the lungs and pancreas play a critical role in repairing damage from wildfire smoke, respiratory viruses, and other toxins. med.stanford.edu/news/all-news/…

Stanford biochemist Lingyin Li is studying a tumor-fighting “miracle molecule” that could one day inform therapies for cancer, as well as autoimmune, neurodegenerative, and age-related diseases: stanford.io/3I5xqfx

New Stanford Medicine-led research indicates that inhibiting the LRRK2 enzyme could stabilize patients with a type of Parkinson’s disease. stan.md/4nucWwY